Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dermapro
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •?Healthy females or males aged 20 to 60 years
- •?Subjects who signed the informed consent; the purpose and the protocol of the study are explained to subjects.
- •?Subjects who are willing to cooperate with the requirements of the study during the test period and contact investigator immediately if they experience any adverse reaction.
- •?Subjects should be cooperative and available for follow\-up during the study period.
Exclusion Criteria
- •?Women who are self\-reported pregnant, nursing or planning a pregnancy
- •?Subjects with a history of any dermatological disease or condition, including but not limited to active atopic dermatitis, psoriasis, eczema, active seasonal allergies within the past a months
- •?Subjects with abnormal skin pigmentation at the test sites which might interfere with subsequent evaluations of dermal responsiveness
- •?Subjects taking medications which might interfere with the test results, including anti\-inflammatory, antihistamines or immunosuppressive drugs
- •?Subjects who have applied any type of topical anti\-inflammatory medication to the test sites within two weeks prior to enrollment
- •?Subjects with any other skin condition that would interfere with the conduct of the study
- •?Subjects with a history of immune deficiency or auto\-immune disease
- •?Subjects who are currently receiving allergy injections, have received allergy injections within one week prior to enrollment, or expect to begin receiving allergy injections during the study
- •?Subjects who are currently under treatment for chronic diseases (asthma and diabetes etc.)
- •?Current enrollment in any other research study or participation in a patch test study within 30 days prior to the start of this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
To evaluate safety of 3 test products for skin irritatioCTRI/2020/09/027690Pontika Aerotech Limited28
Completed
Not Applicable
To evaluate safety of 10 test products for skin irritatioCTRI/2020/03/023749HPC Enterprises Pvt Ltd33
Completed
Not Applicable
To evaluate safety of 1 test product for skin irritatioCTRI/2020/02/023204Redcliffe Hygiene Private Limited25
Completed
Not Applicable
To study the irritation, if any, caused by application of product on skin.CTRI/2019/09/021230Cipla Ltd26
Not yet recruiting
Not Applicable
Patch test to study the irritation potential of the study product.CTRI/2020/01/023041Sami Labs Limited